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Introduction
Exocytosis in response to action potential–evoked membrane 
depolarization has been extensively characterized in the nervous 
system, in which neurotransmitters or hormones are released 
after extracellular Ca2+ influx at synapses in neurons or in neuro-
endocrine cells, respectively. In pancreatic islet  cells, for ex-
ample, glucose elevation results in the closure of KATP channels, 
membrane depolarization, opening of voltage-gated calcium chan-
nels (VGCCs), and, in response to Ca2+ influx, secretion of insulin 
(Yang and Berggren, 2006). At neuronal synapses, neurotrans-
mitter-containing vesicles are docked in close vicinity to VGCCs 
at the presynaptic active zone (Neher, 1998; Zhai and Bellen, 2004; 
Atwood, 2006). Although the spatial proximity of VGCCs and 
exocytic vesicles undergoing fusion with the plasma membrane 
is well documented, the detailed molecular mechanisms involved 
in the spatial and temporal coupling of exocytosis and VGCC 
activation and inactivation remain to be elucidated.
VGCCs are composed of an ion pore–forming Cav1 sub-
unit associated with several auxiliary subunits (Cav, Cav2, and 
Cav; Arikkath and Campbell, 2003). Among the Cav1 subunits, 
the P/Q-type Cav2.1 and the N-type Cav2.2 define the main chan-
nel subtypes important for presynaptic neurotransmitter release 
(Spafford and Zamponi, 2003; Evans and Zamponi, 2006), and 
the L-type Cav1.2 subtype triggers Ca2+-dependent secretion in 
neuroendocrine cells (Catterall, 2000). Four Cav subunit isoforms 
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levels were found in brain, pancreatic islets, and neuroendocrine 
cell lines (MIN6 and PC12), with undetectable or weak expres-
sion in other tissues (Fig. 1 B).
The presence of BARP protein was confirmed in brain and 
PC12 cells using a polyclonal (72) and two affinity-purified 
mAbs (12B1 and 8B2) raised against different regions of the 
protein (Fig. 1 C). Specificity of the different antibody (Ab) was 
validated by the lack of staining in untransfected cells (Fig. S1 B) 
or after preabsorbing the Ab on a GST-BARP fusion protein 
(Figs. S1 C and S2 B) and by the absence of reactivity in pancreas-
specific BARP knockout mice (Fig. S2 C). In COS-1 cells trans-
fected with a Myc-tagged BARP cDNA, the labeling of the 
three Abs predominantly colocalized with that of the anti-Myc 
Ab (Fig. S1 B), but the BARP Ab did not colocalize with a 
Myc-tagged -galactoside used as a negative control.
The predicted initiation methionine for BARP (M1; 
Fig. S1 A) is in accordance with the high quality annotation of 
the protein coding regions of the mouse and human genome by 
the Consensus Coding Sequence Project (Pruitt et al., 2009). 
This is the first conserved Met and the site where the high de-
gree of amino acid identity among BARPs from different species 
starts (Fig. S1 D). In agreement with M1 being the initiation 
methionine, expression in COS-1 cells of mutants lacking either 
M7 or M80, the only two other conserved putative translation 
initiation sites in BARP, showed the same electrophoretic mo-
bility as wild-type (WT) BARP, consistent with initiation of 
translation from M1 (Fig. S1 D). In contrast, the mobility of the 
M1A mutant was detectably faster than WT BARP, presumably 
because in the absence of M1, initiation can occur from M7. 
A truncated translation product was also obtained from the M1A/
M7A mutant, presumably as a result of translation from M80 be-
cause only mutation of all three conserved methionine residues 
abolished translation. Thus, although M1, M7, and M80 can act 
as independent initiation sites, in the full-length cDNA, the codon 
for M1 serves as the main site for the initiation of translation.
BARP overexpressed in COS-1 or human embryonic kidney–
derived tsA201 cells migrated as a doublet of higher molecular 
mass as compared with the in vitro translated BARP (Fig. 1 D), 
suggestive of posttranslational modifications. In PC12 cells, the 
upper band was more prominent. Tunicamycin led to a reduc-
tion of the apparent molecular mass for WT BARP but not for 
a mutant lacking the putative N-glycosylation site (25N-X-S/T), 
consistent with the presence of N-linked glycosylation (Fig. 1 E). 
For better resolution of the different bands by SDS-PAGE, a 
C-terminal truncation of BARP (C-tr145, consisting of aa 1–145) 
was analyzed. After tunicamycin, PNGase F, or Endoglycosi-
dase H treatment, the truncated form of BARP co-migrated with 
the truncated form lacking the N-glycosylation site (Fig. S1 E), 
confirming the presence of this glycosylation. After these treat-
ments, however, BARP still migrated as a doublet, indicating the 
existence of additional unknown posttranslational modifications 
or internal initiation of translation.
The presence of N-terminal carbohydrate chains suggested 
that BARP is a type I membrane protein, with the N terminus 
located on the extracellular side. This topology was validated by 
cell surface labeling experiments, in which N- or C-terminally 
Myc-tagged BARP was expressed in COS-1 cells and the cells 
(Cav1, Cav2, Cav3, and Cav4) show distinct tissue and sub-
cellular distributions (Dolphin, 2003; Buraei and Yang, 2010). 
Cav subunits interact with the 18-aa 1 interaction domain (AID) 
of the cytoplasmic linker between internal repeats I and II of the 
pore-forming 1 subunit (Pragnell et al., 1994; Chen et al., 2004; 
Opatowsky et al., 2004; Van Petegem et al., 2004). Cav subunits 
enhance VGCC channel activity (Mori et al., 1991; Chien et al., 
1995; Josephson and Varadi, 1996; Kamp et al., 1996; Brice et al., 
1997; Jones et al., 1998; Colecraft et al., 2002), not only by fa-
cilitating cell surface transport of VGCCs and by preventing ER-
associated protein degradation (Altier et al., 2011) but also by 
modulating their gating properties (Buraei and Yang, 2010).
VGCCs interact via the Cav1 subunit with several pre- and 
postsynaptic proteins, including SNAP-25, synaptotagmin, syn-
taxin, Mint, and calcium/calmodulin-dependent serine protein ki-
nase (Sheng et al., 1994; Bezprozvanny et al., 1995; Zhong et al., 
1999; Maximov and Bezprozvanny, 2002; Spafford and Zamponi, 
2003; Nishimune et al., 2004; Kang et al., 2006). The interaction 
and clustering of VGCCs with components of the secretory vesi-
cle docking and fusion machinery by multiprotein adaptors high-
lights the importance of the spatial and temporal coordination of 
Ca2+ entry and neurosecretion (Yang and Berggren, 2006). The 
Cav subunits also interact with regulatory proteins that inhibit 
(e.g., RGK proteins, calcium, heterotrimeric G proteins, opioid 
receptor–like receptor 1, and several synaptic proteins) or facili-
tate VGCC activity (e.g., Rim1) or both (e.g., calmodulin; Herlitze 
et al., 1996; Ikeda, 1996; Lee et al., 1999; Béguin et al., 2001, 
2005a,b, 2006, 2007; Beedle et al., 2004; Chen et al., 2005; Finlin 
et al., 2005; Evans and Zamponi, 2006; Jarvis and Zamponi, 
2007; Kiyonaka et al., 2007; Buraei and Yang, 2010; Flynn and 
Zamponi, 2010; Yang et al., 2010).
Here, we describe a previously uncharacterized protein, 
which we term the VGCC–-anchoring and -regulatory protein 
(BARP), and characterize its role in the regulation of VGCC ac-
tivity and Ca2+-regulated exocytosis. BARP is highly expressed 
in several specific neuronal populations and neuropeptide secre-
tory cells, plays a role in the recruitment of Cav subunits to the 
plasma membrane, and negatively regulates VGCCs by interfer-
ing with the association of the Cav subunit with the Cav1 sub-
unit. We hypothesize that BARP serves as an adaptor protein 
that modulates Cav subunit localization and their association 
with Cav1 subunits to regulate VGCC activity.
Results
Identification, tissue-specific expression, 
and membrane topology of BARP
BARP was identified in a yeast two-hybrid screen of a mouse 
insulin-secreting MIN6 cell cDNA library using Cav3 as bait. 
BARP is encoded by an open reading frame of unknown func-
tion, C19orf26, which, based on its chromosomal location, has 
also been referred to as Dos (downstream of Stk11 kinase; 
Gerhard et al., 2004). Sequence analysis of EST clones and cDNA 
cloned from libraries revealed a 3-kb transcript, coding for a 
698-aa protein. BARP contains no known functional domains ex-
cept for a single putative transmembrane domain and a putative 
N-glycosylation site (Figs. 1 A and S1 A). High BARP mRNA 
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Figure 1. Characterization of BARP. (A) Structural and functional domains. The N-glycosylation site (Y), transmembrane region (blue), and the Cav-
interacting domain I and II (green) are depicted. Amino acid sequences of domain I and II, with residues crucial for interaction with Cav are in orange. 
(B) Northern blot analysis. BARP mRNA expression was analyzed in the indicated mouse and human tissues and cell lines. The samples were run on three 
separate gels, as shown. (C) WB analysis. Endogenous BARP protein was detected in brain and PC12 cells by WB using a rabbit polyclonal Ab (72) or 
two mouse mAb (12B1 and 8B2) raised against different regions of the protein. (D) Comparison of in vitro synthesized and cell-expressed BARP protein. 
BARP obtained by in vitro translation or from transfected COS-1, tsA201, or PC12 cells was analyzed by SDS-PAGE and WB (mAb 12B1). (E) BARP is 
N-glycosylated on Asn25. COS-1 cells expressing WT BARP or a BARP mutant lacking the putative N-glycosylation site (N25Q) were treated with tunicamycin 
to inhibit N-glycosylation. Cell lysates were analyzed by Tris/acetate-PAGE WB (Ab 72). (F) Membrane topology of BARP. Nonpermeabilized (cell surface 
labeling) or permeabilized (cell expression) are depicted. COS-1 cells expressing N- or C-Myc BARP were stained with an Ab to Myc and visualized by 
immunofluorescence microscopy. In nonpermeabilized cells (a and c), only the N-terminally tagged BARP was detected.
JCB • VOLUME 205 • NUMBER 2 • 2014 236
Figure 2. Neuronal expression of BARP. (A) Expression of BARP in brain (a) and pancreatic islets (b). Sections of cortex (1), hippocampus (2), and cerebel-
lum (3) stained for BARP (mAb 12B1) and analyzed by immunofluorescence microscopy. BARP is detected in cell bodies and the dendritic extensions of 
Purkinje (white arrows) and pyramidal (green arrow) cells. In pancreatic islets, BARP is expressed in insulin-positive  cells but absent from  cells labeled 
for glucagon. The inset shows a higher magnification of the Purkinje cell layer. (B) Neuronal expression of BARP. Primary cells isolated from hippocampus or 
cerebellum were costained with mAb 12B1 to BARP and Ab to the neuronal marker MAP2 (a), the glial marker GFAP (b), the Purkinje marker calbindin (d), 
or the dense core vesicle protein BDNF (f). The insets show a higher magnification of the vesicular staining in the soma. Nuclei were stained with Hoechst 
(blue). (C) Colocalization of BARP with synaptotagmin in PC12 cells. Control or NGF-differentiated PC12 cells were costained with Ab to the regulated 
secretory vesicle marker synaptotagmin and BARP (Ab 72) and analyzed by confocal microscopy.
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were labeled with antitag Ab either before (cell surface labeling) 
or after (cell expression) cell permeabilization. Only N-terminally 
tagged BARP was detected by incubating nonpermeabilized in-
tact cells with Ab to Myc, thus confirming the extracellular expo-
sure of the N terminus (Fig. 1 F).
Neuronal and pancreatic expression and 
subcellular localization of BARP
Immunolabeling of mouse tissue sections revealed BARP pro-
tein in the cortex, cerebellum, and hippocampus of the brain 
(Fig. 2 A, a) and in pancreatic islets (Figs. 2 A, b; and S2 C), 
consistent with the Northern blot analysis (Fig. 1 B). During 
mouse development, BARP expression in the brain peaked 
between embryonic day 18 (E18) and postnatal day 7 (P7; 
Fig. S2 A). In the cortex and hippocampus, BARP was detected 
in pyramidal cell bodies and dendrites. In the cerebellum, BARP 
was exclusively expressed in Purkinje cells, uniformly in soma 
and the main dendritic shaft and as a patchy staining along the 
distal dendrites (Figs. 2 A, a; and S2 B). Costaining of cultured 
primary cells isolated from hippocampus and cerebellum with 
BARP and neuronal (MAP2 and calbindin) or glial (glial fibril-
lary acidic protein [GFAP]) markers confirmed the neuron-
specific expression of BARP (Fig. 2 B). In cerebellar primary 
cells, BARP was present in calbindin-positive Purkinje cells, 
where it localized to the cell soma, the dendritic shaft, and along 
the axon, including the presynaptic button, and colocalized 
with the dense core vesicle marker brain-derived neurotrophic 
factor (BDNF).
In PC12 cells, BARP partially colocalized with the 
Ca2+-dependent secretory vesicle markers synaptotagmin I and, 
upon NGF-induced differentiation, localized to the growth cone 
(Fig. 2 C). In contrast to the more prominent vesicular staining 
of endogenous BARP in PC12 cells (Fig. 3 C, b), BARP over-
expressed in PC12 or other cell lines was enriched at the plasma 
membrane (Fig. S2, D and F). Such a difference in distribution 
was also reported for endogenous versus overexpressed synap-
totagmin I (Vega and Hsu, 2001) and could be reproduced in our 
PC12 cells (compare Figs. 2 C and S2 D). This was interpreted 
Figure 3. BARP binds and localizes Cav subunits to the plasma mem-
brane. (A) Coimmunoprecipitation of Cav and BARP. COS-1 cells were 
cotransfected with cDNAs for BARP and the different Flag-tagged Cav  
subunit or, as a control, Flag–-galactosidase (-gal). Flag-tagged pro-
teins were immunoprecipitated (IP), and bound BARP was detected by WB 
(Ab 72). The association was confirmed by reciprocal immunoprecipitation. 
Aliquots of cell lysates were analyzed by WB to monitor protein expression. 
(B) BARP localizes Cav subunits to the plasma membrane. (a) PC12 cells 
were transfected with cDNAs for the different Flag-Cav subunits, either 
alone or with a Myc-BARP cDNA. Cells were analyzed by immunofluores-
cence microscopy using Ab to Flag and Myc to detect the Cav subunits 
and BARP, respectively. Colocalization index is shown in the rightmost 
images. (b) Costaining of PC12 cells cotransfected with cDNAs for 
N-Flag–-galactosidase, and Myc-BARP cDNA served as a negative control. 
(C) Constitutive overexpression of BARP relocates endogenous Cav sub-
units. (a) Protein expression. WB analysis of lysates from control PC12 
Tet-On cells or cells constitutively expressing BARP. The asterisk indicates a 
nonspecific protein band. (b) Localization of endogenous Cav subunits to 
the plasma membrane upon BARP expression. Endogenous Cav subunits 
and endogenous (a–f) or stably overexpressed BARP (g–l) in PC12 Tet-On 
cell lines were detected by immunofluorescence microscopy. Colocaliza-
tion index is shown in the rightmost images. The dotted lines delimit the 
cloud shape of the colocalization index. Note that imaging of endogenous 
BARP required a 10× longer exposure to obtain a comparable intensity to 
overexpressed BARP.
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Figure 4. BARP associates with Cav subunits via domain I and domain II. (A) Identification of BARP domain I (Dom.I) as a Cav-interacting domain. 
(a) Amino acid sequence of domain I and AID. The predicated (BARP) or known (Cav1.2 AID)  helix and amino acids important for Cav binding (under-
lined) are shown. (b) Identification of amino acids in domain I important for binding to the Cav. COS-1 cells expressing Flag-Cav3 and WT or mutated 
239BARP regulates Ca2+ channel activity and secretion • Béguin et al.
GST-BARP domain I were lysed, GST fusion (fus.) proteins were precipitated, and the associated Cav3 was detected by WB. As a control, Cav3 was 
coprecipitated with WT or mutated GST-Cav1.2 AID. Aliquots of cell lysates were analyzed by WB to monitor protein expression. The black line indicates 
the rearrangement of lanes for presentation purposes. (c) Identification of amino acids in Cav3 important for binding to BARP domain I. COS-1 cells ex-
pressing GST-BARP domain I or GST-AID with mutated Flag-Cav3 were lysed, GST fusion proteins were precipitated, and associated Cav3 was detected 
by WB. Aliquots of cell lysates were analyzed by WB to monitor protein expression, using two separate gels, as shown. PPT, precipitation. (B) Identifica-
tion of BARP domain II as a second Cav subunit binding region. (a) Amino acid sequence of domain II with residues crucial for the association with Cav 
(red). (b) Identification of amino acids in domain II important for Cav binding. COS-1 cells expressing Flag-Cav3 and WT or mutated GST-BARP domain II 
were lysed, GST-BARP domain II was precipitated, and the associated Flag-Cav3 was detected by WB. Aliquots of cell lysates were analyzed by WB 
to monitor protein expression. (C) Role of domains I and II in the context of full-length BARP in Cav binding. COS-1 cells expressing WT BARP or the 
BARP domain I and/or domain II mutants and Flag-Cav3 were lysed, Flag-Cav3 was immunoprecipitated (IP), and the associated BARP was revealed by 
WB (Ab 72). In a reciprocal experiment, BARP was immunoprecipitated, and bound Flag-Cav3 was detected. Aliquots of cell lysates were analyzed by 
WB to monitor protein expression. (D) Roles of domains I and II in the context of full-length BARP in Cav3 membrane recruitment. PC12 cells expressing 
Flag-Cav3 and either BARP WT or mutants affecting domain I and/or domain II were labeled with Ab to Flag (green) and BARP (Ab 72) and processed 
for immunofluorescence microscopy. Colocalization index is shown in the rightmost images. The dotted lines delimit the cloud shape of the colocalization 
index. (d–f) Mutation of both domains I and II (db) in BARP abolishes the localization of Cav3 to the plasma membrane.
 
to reflect a shift in the steady-state distribution from a more 
prominent vesicular to a more pronounced plasma membrane 
localization after overexpression (Han et al., 2004; Atiya-Nasagi 
et al., 2005).
BARP binds and localizes the different Cav 
subunit isoforms to the plasma membrane
Coimmunoprecipitation experiments using BARP and the dif-
ferent Cav subunit isoforms overexpressed in COS-1 cells es-
tablished that BARP binds to all the different Cav isoforms 
(Fig. 3 A). These associations were corroborated in intact cells 
using immunofluorescence experiments. When overexpressed 
in PC12 (Fig. 3 B) or COS-1 (Fig. S2 E) cells, the Cav subunits 
showed, with the exception of Cav2a, a cytosolic distribution 
with some degree of nuclear labeling for Cav3 and Cav4a 
(Dolphin, 2003). Remarkably, overexpression of BARP localized 
the cytosolic Cav isoforms to the plasma membrane. This con-
firms that the two proteins interact in a cellular context and shows 
that BARP can influence the subcellular distribution of Cav sub-
units in the absence of Cav1. The colocalization index, which in 
this context reflects the efficiency of recruitment of the different 
Cav subunits by BARP, did not drastically differ, indicating a 
similar effect of BARP for all isoforms. As a control, BARP M1A/
M7A, which utilizes M80 for initiation of translation (Fig. S1 D) 
and thus lacks the first 79 aa and hence the transmembrane do-
main, failed to localize Cav3 to the plasma membrane (Figs. 3 B, 
a; and S2 E).
When BARP was constitutively and stably overexpressed 
from a cytomegalovirus promoter in PC12 Tet-On cells (BARP10; 
Fig. 3 C, a), the localization of endogenous BARP changed from 
a vesicular pattern in parental cells to a prominent peripheral 
staining in BARP-overexpressing cells (Fig. 3 C, b). Concomi-
tantly, endogenous Cav1 and Cav3, which poorly colocalized 
with endogenous BARP in untransfected cells, redistributed to 
the cell periphery upon BARP overexpression (Fig. 3 C, b).
BARP encodes two distinct  
Cav-binding domains
To obtain additional insight into the mechanism by which BARP 
associates with VGCCs, the domains in BARP required for 
its interaction with the Cav subunit were identified. Deletion 
and alanine-scan mutagenesis of BARP combined with yeast 
two-hybrid screening (Fig. S3, A and B) and GST pull-down 
experiments (Fig. S3, C and E) narrowed down the interaction 
with Cav subunits to two domains, termed domain I and do-
main II. Based on in silico molecular dynamics simulations, do-
main I (aa 422–442; Fig. 4 A, a) is predicted to fold into an 
 helix (Fig. S3 D). Mutation of L426, W427, or R430 in BARP 
abolished the interaction of domain I with the Cav subunit 
(Fig. 4 A, b). The AID of the Cav1 subunit and mutants carry-
ing substitutions of aa Y467, W470, and I471, known to be im-
portant for binding to Cav (Richards et al., 2004), served as a 
control (Fig. 4 A, a and b).
Previous studies, including crystallographic analysis, es-
tablished that the AID is associated as an  helix with a hydro-
phobic groove in Cav, also termed the AID-binding pocket 
(ABP; Pragnell et al., 1994; Chen et al., 2004; Richards et al., 
2004; Van Petegem et al., 2004). To explore whether domain I 
could also bind to the ABP, mutations in this region of Cav 
were generated, and their effect on the interaction with BARP 
was tested. Substitutions of several amino acids in the hydro-
phobic pocket of the Cav subunit impaired its association with 
BARP domain I (Fig. 4 A, c). This was not caused by an effect 
of the mutations on the folding of Cav because, with the excep-
tion of M196A, the different Cav mutants still bound the AID.
Because a truncated BARP that lacked domain I still inter-
acted with Cav, analysis of additional BARP mutants (Fig. S3 E) 
led to the identification of a second binding region, domain II 
(aa 525–563; Fig. 4 B, a). Amino acid substitutions in domain II 
revealed two leucine-phenylalanine pairs (L545-F546 and F549-
L550) as important for efficient Cav binding (Fig. 4 B). Inter-
estingly, the isolated BARP domain II interacted with Cav3, 
Cav2a, Cav2b, and Cav4a but not with Cav1a, whereas 
domain I bound all Cav subunits tested (Fig. S3 F).
The effect of the amino acids substitutions in domain I 
(L426A and W427A) and/or domain II (L545A, F546A, F549A, 
and L550A) on the association with Cav was next analyzed 
in full-length BARP. Simultaneous mutation of both domains 
abolished the association of the mutated BARP with the Cav 
(Fig. 4 C). Although the interaction between BARP and Cav was 
more sensitive to the disruption of domain I, the presence of one 
intact domain was sufficient to confer not only detectable binding 
but also plasma membrane localization of the Cav subunits in 
cells (Figs. 4 D and S3 H). However, the colocalization index 
suggests that domain II alone mediates a less efficient localization 
JCB • VOLUME 205 • NUMBER 2 • 2014 240
cells overexpressing WT BARP, but not BARP with domains I 
and II mutated, a drastic reduction in P/Q- or N-type channel 
Ca2+ currents was recorded (Figs. 6, A and B, a and c; and S5 A). 
Mutation of domain I or II individually resulted in a partial re-
duction of Ca2+ channel activity (Figs. 6, A and B, b and c; and 
S5 A). Inactivation kinetics in the presence or absence of WT 
BARP did not significantly differ (P/Q-type channel: control = 
78 ± 12 ms, n = 20 [Kameyama et al., 1999]; WT BARP = 80 ± 
23 ms, n = 17).
To analyze whether a defect in Ca2+ channel surface expres-
sion in the presence of BARP accounts for its inhibitory effect on 
Ca2+ currents, we monitored Cav1.2 trafficking in tsA201 cells. 
Similar to BHK cells expressing N or P/Q Ca2+ channel subtypes 
(Fig. 6, A and B), BARP inhibited Ca2+ channel activity in tsA201 
cells coexpressing Cav1.2 and Cav3 (Fig. 6 C). This inhibition 
was abrogated if both domains I and II were mutated and par-
tially reduced if domain I or II was mutated independently.
Detection of Cav1.2 on the surface of nonpermeabilized 
intact tsA201 cells (Altier et al., 2002; Béguin et al., 2006) re-
quired coexpression with one of the Cav subunits (Figs. 6 D, a; 
and S5 B), and accordingly, mutation of the AID abolished Ca2+ 
channel cell surface transport (Fig. 6 D, a). Coexpression of 
Cav1.2 subunits with BARP, either in the absence or presence of 
Cav3, did not significantly affect Ca2+ channel surface expres-
sion (Fig. 6 D, a). Relative cell surface expression of Cav1.2 in 
the presence or absence of Cav3 and/or BARP was corrobo-
rated and quantified by coexpressing in tsA201 cells a Cav1 
subunit carrying both a luminal (HA) and a cytosolic (EGFP) 
tag and measuring relative pixel intensities in intact and perme-
abilized cells (Fig. 6 D, b and c). Although Cav3, either in the 
absence of presence of BARP, significantly increased the frac-
tion of Cav1 at the cell surface (0.12 ± 0.02 vs. 0.39 ± 0.03, 
P < 0.01), BARP had no significant influence on Cav1.2 distri-
bution (Fig. 6 C, c). Thus, BARP does not significantly interfere 
with the role of Cav in facilitating cell surface expression of 
Ca2+ channels and thus most likely inhibits channel activity at 
the plasma membrane.
BARP negatively modulates VGCC activity 
and Ca2+-regulated secretion
To elucidate the role of BARP in physiological processes linked 
to VGCC function, we explored the effects of BARP on VGCC 
activity and Ca2+-dependent hormone secretion in PC12 cells 
(Béguin et al., 2001). First, we took advantage of the observation 
that endogenous BARP expression varies in different PC12 clones 
and is higher in ATCC PC12 cells (CRL-1721) than in PC12 Tet-
On cells (Takara Bio Inc.; Fig. 7 A, a). Correlating with the differ-
ent BARP expression levels in these cells, endogenous Ca2+ 
channel current densities were lower in ATCC PC12 cells and 
significantly inhibited in PC12 Tet-On cells stably expressing 
BARP (Fig. 7 A, b). These results were corroborated in PC12 
cells transiently expressing BARP. An almost complete reduction 
of endogenous Ca2+ currents was recorded in cells overexpressing 
WT BARP, whereas BARP with both domains I and II mutated 
had no significant effect on VGCC activity (Fig. 7 B).
Importantly, inhibition of VGCC activity by BARP had an 
effect on Ca2+-triggered exocytosis (Fig. 7 C). Correlating with 
of Cav3 to the plasma membrane (0.68 ± 0.05) compared with 
WT BARP (0.80 ± 0.02) or BARP with domain II mutated (0.80 ± 
0.02, P < 0.05).
BARP modulates the interaction between 
the Cav and Cav1 subunits
Because BARP domain I binds to the ABP in Cav, BARP may 
interfere with the interaction between Cav and Cav1. To test 
this hypothesis, we monitored the stability of a preassembled 
complex between the Cav3 and a GST-AID fusion protein after 
addition of competitive peptides coding for domain I or, as a 
control, the AID. Indeed, Cav3 was displaced by soluble do-
main I or AID peptides from the immobilized GST-AID and re-
covered in the supernatant (Fig. 5 A), consistent with BARP 
domain I and the AID binding in a mutually exclusive manner 
to the same or an overlapping site in Cav. Slightly higher con-
centrations of domain I peptide than AID peptide were required 
for disruption of the complex.
The biochemical results were corroborated in a cellular 
context by coexpressing BARP, Cav3, and Cav1 and monitor-
ing their associations in coprecipitation experiments. In the 
presence of WT BARP, the Cav3 and Cav1 subunits no longer 
associated (Fig. 5 B). In contrast, coprecipitation was not affected 
in the presence of BARP with both domain I and II mutated. 
Mutation of either domain individually partially interfered with 
the association between the Cav3 and Cav1, showing the impor-
tance of domain I and II. Interestingly, mutation of domain I alone 
allowed the detection of a ternary complex containing BARP, 
Cav1, and Cav3 (Fig. 5 B, lane 3). As a control, neither Cav3 
nor BARP associated with a mutated Cav1 subunit unable to 
bind Cav3 (Fig. S4 A), suggesting that BARP does not bind to 
Cav1 directly. Similar results were also obtained for Cav3 in 
combination with other 1 subunit subtypes (e.g., Cav2.1 and 
Cav2.2; Fig. S4, B and C) and for other Cav subunit isoforms 
(e.g., Cav1a, Cav2a, Cav2b, and Cav4a; Fig. S4 D).
Coimmunoprecipitation experiments from PC12 cells and 
the brain confirmed that also endogenous BARP and Cav3 asso-
ciate with each other (Fig. 5 C). Interestingly, comparison of the 
amount of endogenous Cav3 that was bound to either endoge-
nous or overexpressed BARP in PC12 cells suggested the presence 
of a significant pool of Cav3 that is not associated with endoge-
nous BARP. In addition to Cav3, BARP associated with Cav4 
in cerebellum and cerebrum and to a lesser extent with Cav1 in 
the latter (Figs. 5 D and S4 E).
BARP inhibits VGCC activity without 
affecting cell surface expression of VGCCs
Cav subunits modulate Ca2+ channel activity by increasing 
channel current density at the plasma membrane and/or facili-
tating the trafficking of newly synthesized Cav1 subunits from 
the ER to the plasma membrane (Chien et al., 1995; Dolphin, 
2003). To explore the functional role of BARP in regulating VGCC 
activity, BHK cells stably expressing Cav1 (Cav2.1 or Cav2.2), 
Cav1a, and Cav2 subunits to reconstitute P/Q- or N-type 
VGCCs (Niidome et al., 1994) were transfected with or without 
WT or mutated BARP cDNAs (Fig. 6, A and B) and subjected 
to electrophysiological analysis. Compared with controls, in 
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data establish BARP as a negative regulator of Ca2+-dependent 
exocytosis, most likely by modulating VGCC activity at the 
plasma membrane.
Silencing of BARP enhances VGCC activity 
and Ca2+-evoked secretion
We next analyzed the effect of silencing BARP in ATCC PC12 
cells because these express significant levels of the protein en-
dogenously (Fig. 7 A, a). Three shRNAs (A, B, and C) that tar-
get different regions of the BARP mRNA (Fig. 8 A, a) were 
stably transfected into PC12 cells, and two independent clones 
for each shRNA were selected. Expression levels of BARP in 
the Ca2+ channel recordings, overexpression of BARP strongly 
inhibited Ca2+-dependent growth hormone secretion. Mutation 
of either domain I or II individually led to intermediate effects, 
whereas BARP carrying mutations in both Cav subunit bind-
ing sites only marginally affected growth hormone secretion.
Relative cell surface expression of Cav1.2 in the presence or 
absence of Cav3 and/or BARP was also analyzed in PC12 cells 
as described for tsA201 cells (Fig. 6 D, b and c). Although Cav3, 
either in the absence or presence of BARP, significantly increased 
the fraction of Cav1 at the cell surface (0.22 ± 0.01 vs. 0.45 ± 
0.01, P < 0.01), BARP had no significant influence on Cav1.2 
channel distribution in PC12 cells (Fig. 7 D). Collectively, these 
Figure 5. Competition between the AID of Cav1 and BARP domain I for Cav binding and association of endogenous BARP and Cav. (A) BARP domain I 
(Dom.I) peptides dissociate a preformed AID–Cav3 complex. Flag-Cav3 expressed in COS-1 cells was isolated using a GST-AID fusion protein. The 
complex was incubated with increasing amounts of AID or BARP domain I peptide as indicated. Flag-Cav3 displaced from the immobilized GST-AID was 
recovered in the supernatant and detected by WB using two separate gels, as shown. No Flag-Cav3 was detected in the supernatant in the absence of 
peptides, showing that the immobilized Cav3–AID complex did not dissociate over the duration of the experiment. (B) BARP overexpression interferes with 
the association between Cav and Cav1.2 subunits. COS-1 cells were cotransfected with cDNAs for WT or mutated BARP together with Flag-Cav3 and 
HA-Cav1.2 subunits. Flag-Cav3, HA-Cav1.2, or BARP was immunoprecipitated (IP), and the associated Ca2+ channel subunits or BARP was revealed by 
WB. Aliquots of cell lysates were analyzed by WB to monitor protein expression. db, both domains I and II mutated. (C) Association of endogenous BARP 
with Cav3 in PC12 cells and brain. Endogenous Cav3 was immunoprecipitated from PC12 cells or brain lysates, and the associated endogenous BARP 
was revealed by WB (mAb 12B1). In a reciprocal experiment, BARP was first immunoprecipitated (mAb 8B2), and bound Cav3 was detected. Control 
IgG did not pull down BARP or Cav3 (lanes 1 and 7). Aliquots of the cell lysates were analyzed by WB using two separate gels, as shown, to monitor the 
expression of endogenous or overexpressed proteins. The asterisk shows the band for IgG heavy chain. (D) Association of endogenous BARP with Cav1, 
Cav3, and Cav4 in the cerebrum and cerebellum. Endogenous Cav subunits were immunoprecipitated from lysates, and the associated endogenous 
BARP was revealed by WB (mAb 12B1). Control IgG did not pull down BARP (lanes 2 and 6). Aliquots of the cell lysates were analyzed by WB to monitor 
BARP expression. Black lines indicate the rearrangement of lanes for presentation purposes. In addition, note that lane 1 represents a shorter exposure of 
the same membrane than the other lanes. The asterisks show the band for IgG heavy chain and a nonspecific band that did not coprecipitate with Cav.
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Figure 6. BARP down-regulates voltage-gated Ca2+ channel activity without affecting its cell surface expression. (A–C) BARP down-regulates VGCC 
activity. Effect of BARP on activity of P/Q (A)- or N (B)-type Ca2+ channels reconstituted in BHK cells or on VGCCs in tsA201 cells (C). (A and B) BHK 
cells stably expressing Cav2.1 (P/Q type) or Cav2.2 (N type) together with Cav1a and Cav2 were transfected with a vector carrying WT or mutated 
BARP and EGFP cDNAs, and cells expressing EGFP were selected for electrophysiology. (C) tsA201 cells were cotransfected with a vector carrying WT 
or mutated BARP and mCherry cDNAs, a vector containing Cav1.2, and an internal ribosomal entry site followed by Cav3 and EGFP cDNAs, and cells 
expressing mCherry and EGFP were selected for electrophysiology. Current–voltage (I–V) relationships of the different Ca2+ channels in the different cells 
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concentration of BARP (e.g., domain I) could thus be sufficiently 
high to modulate the Cav1 AID–Cav interaction. Alterna-
tively, a cooperative binding of domains I and II could increase 
the affinity of BARP for the Cav, and/or domain II binding 
could alter the conformation of Cav and thereby lower the 
affinity of Cav for the AID (Fig. S5 D). Consistent with this 
hypothesis, cellular overexpression of BARP abolished the as-
sociation between Cav and Cav1 only if domain II–mediated 
binding was preserved. Posttranslational modifications of BARP 
or a binding protein may also regulate the cooperation between 
domains I and II for Cav association. The region in Cav that 
interacts with domain II has not been identified but could in-
volve the SH3 and/or HOOK domain because they show the 
highest divergence between Cav1a, which does not bind do-
main II, and the other Cav isoforms (Fig. S3 G).
In the hippocampus and Purkinje cells, in which BARP 
is expressed, Cav1 is mostly present in soma and dendrites, 
whereas Cav3 and Cav4 are found in axons and other parts of 
the neurons (Obermair et al., 2010). Interestingly, in the cerebrum 
and cerebellum, BARP coprecipitated with Cav3 and Cav4 but 
not, or only to a lesser extent, with Cav1, suggesting that BARP 
may associate with specific Cav subunits in particular subcel-
lular domains of neurons. For instance, BARP colocalized with 
BDNF, indicating its presence on dense core vesicles (Dieni et al., 
2012). Intriguingly, during mouse development, BARP expres-
sion in the brain peaks between E18 and P7, a period crucial for 
neural circuit formation and synaptogenesis (Ullian et al., 2004; 
Christopherson et al., 2005).
Cav subunits facilitate surface expression of L-type VGCC 
by preventing ER-associated protein degradation of Cav1.2 
(Altier et al., 2011). In tsA201 and PC12 cells, BARP inhibits 
VGCC activity without significantly altering the distribution of 
the Cav1 subunit between the cell surface and intracellular com-
partments and is thus unlikely affecting ER exit and stability of 
Cav1. However, it is well documented that Cav plays an impor-
tant role in modulating, mainly via the IS6-AID linker, not only 
VGCC trafficking but also gating, including voltage-dependent 
activation, inactivation, and facilitation kinetics (Buraei and Yang, 
2010). For instance, RGK GTPases, through association with 
Cav and/or Cav1, not only regulate cell surface expression of 
VGCCs but also directly modulate currents of the channel at 
the plasma membrane by lowering channel opening probabilities 
and/or immobilizing VGCC voltage sensors (Fan et al., 2010; 
Yang et al., 2010). The time course of the macroscopic current in 
the six PC12 clones analyzed ranged between 10 and 25% of 
controls (Fig. 8 A, b and c), and VGCC Ca2+ current densities 
in these clones were between 50 and 140% higher than in con-
trols (Fig. 8 A, d). The stimulatory effect of the shRNAs on 
VGCC activity could be suppressed by transfecting a rescue 
mouse BARP cDNA not targeted by the shRNAs (Fig. 8 A, d, 
red bars).
Endogenous BARP expression was also silenced by transient 
transfection of PC12 cells with a combination of two siRNAs 
(Fig. 8 B, a and b). Neurotransmitter release in these cells was 
analyzed to determine whether the Ca2+-evoked secretion was 
also affected by silencing BARP. No significant differences in the 
basal secretion of acetylcholine were apparent between control 
and BARP siRNA–transfected cells (Fig. 8, c). However, upon 
stimulation with high K+ to depolarize the plasma membrane and 
in turn activate VGCCs, an almost twofold higher secretion of 
the neurotransmitter was observed in BARP siRNA–transfected 
PC12 cells as compared with controls. These results are thus con-
sistent with a negative regulatory role for BARP on VGCC activ-
ity and Ca2+-regulated secretion.
Discussion
The biochemical and functional data presented establish BARP 
as a novel VGCC regulatory protein that exerts its effect by 
binding to Cav subunits and thereby interferes with the associ-
ation of Cav with Cav1, leading to the inhibition of Ca2+ 
channel activity. Two domains in BARP associate with Cav. 
Mutation of domain I to abolish its interaction with Cav allows 
BARP to associate, via domain II, with Cav and Cav1 to form 
a ternary complex. This ternary complex is not detected in the 
presence of a functional domain I, likely because domain I pre-
vents a stable association between Cav1 and Cav, and could 
thus in vivo be short lived or transient. Domain I is predicted to 
acquire an -helical structure that interacts with the ABP in 
Cav. In vitro, the binding between domain I and the ABP occurs 
in the nanomolar range and is of lower apparent affinity than the 
binding of the AID to Cav, which ranges from 2 to 54 nM, de-
pending on the particular Cav1 and Cav species (De Waard et al., 
1995; Bell et al., 2001; Cantí et al., 2001; Geib et al., 2002; 
Opatowsky et al., 2003). In cells, however, evidence suggests 
that the Cav1 and Cav interaction has a lower affinity and is 
reversible (Hidalgo et al., 2006; Buraei and Yang, 2010). A local 
expressing the different BARP proteins (a and b) as well as the traces for P/Q (c)- and N (Fig. S5 A)-type channel recordings are shown. Three independent 
experiments were performed each, and the data were combined to obtain the indicated n values. Shown are the means ± SEM. Paired Student’s t test at 
20 mV. For P/Q-type channels, control versus BARP WT or domain II mutated (P < 0.01) and control versus BARP domain I mutated (P < 0.05) are shown. 
For VGCCs in tsA201 cells, control versus BARP WT and domains I or II mutated (P < 0.01) are shown. For better readability, the data are plotted in two 
individual graphs; hence, the curve for the controls in a and b is identical. (D) BARP does not affect cell surface expression of Ca2+ channels in tsA201 
cells. (a) Cell surface expression of HA epitope–tagged Cav1.2 and N-Myc–BARP was monitored in the presence or absence of Cav3 by immunofluores-
cence microscopy. tsA201 cells were cotransfected with cDNAs for WT HA-Cav1.2 or an AID mutant defective in Cav3 binding, Myc-BARP, and Cav 
isoforms. Cav1.2 and BARP expressed at the cell surface in nonpermeabilized cells were detected using Ab to the extracellular HA epitope in Cav1.2 and 
Myc in BARP. (b) Cell surface expression of N-EGFP/HA-Cav1.2 and N-Myc–BARP was monitored in the presence or absence of Cav3. tsA201 cells were 
cotransfected with cDNAs for N-EGFP/HA-Cav1.2 alone (A) either together with N-Flag–Cav3 (B) or N-Myc–BARP (C) or with Flag-Cav3 and WT BARP 
or BARP with domains I and II mutated (D and E). Cav1.2 and BARP expressed at the cell surface in nonpermeabilized cells were detected using Ab to the 
extracellular HA epitope in Cav1.2 and Myc in BARP. Cellular expressions of EGFP-Cav1.2 and Cav3 are shown. Merged images are shown on the right. 
(c) Quantification of channel cell surface expression is stated as the relative surface expression of HA versus EGFP-Cav1.2 (red/green). Unpaired Student’s 
t test: *, P < 0.01. db, both domains I and II mutated; Dom., domain.
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the presence of BARP was not modified, suggesting that single 
channel conductance, opening probability, or sensor movement 
rather than the kinetic or activation threshold is affected. More 
detailed electrophysiological studies of single channel dynam-
ics will be required to elucidate how BARP affects VGCC activ-
ity. Although BARP does not alter surface expression of the 
Cav1 subunit in tsA201 and PC12 cells, we cannot rule out an 
effect on VGCC trafficking in other cell types and/or under cer-
tain conditions.
One possible function of BARP could be that of an accep-
tor/donor for the reversible transfer of Cav from/to the Cav1 
subunit. Such a reversible transfer could provide an attractive 
mechanism to retain the Cav in the active zone to allow for the 
rapid modulation of VGCC activity. Thus, BARP may provide 
the first example of a negative modulation though the displace-
ment of Cav from the Cav1 subunit. The presynaptic protein 
Rim1 also interacts with Cav to anchor it to secretory vesicles 
(Kiyonaka et al., 2007; Gandini et al., 2011; Weiss et al., 2011), but 
in contrast to BARP, Rim1 stimulates Ca2+-dependent secretion 
by preventing voltage-dependent VGCC inactivation (Kiyonaka 
et al., 2007).
BARP is abundant in the brain and pancreas, in which 
Ca2+-regulated exocytosis through activation of L-type VGCC 
plays important roles in the release of neurotransmitters and 
hormones. Calcium channelopathies are congenital or nonin-
herited muscular, neurological, and cardiac diseases associated 
with the gain or loss of VGCC function (Bidaud et al., 2006). 
Ca2+ channel inhibitors represent one of the most active areas 
of pharmacological drug development. Overexpression of BARP, 
or peptides encoding domains I and/or II, may be used as 
Figure 7. BARP down-regulates VGCC activity at the plasma membrane 
and inhibits Ca2+-dependent hormone secretion in PC12 cells. (A) Expression 
of endogenous BARP in different PC12 cell lines and VGCC Ca+ current 
recordings in ATCC PC12 cells, PC12 Tet-On cells, and PC12 Tet-On cells 
stably overexpressing BARP (BARP10). (a) WB analysis. BARP detected in 
lysates from PC12 cells (ATCC) and PC12 Tet-On cells using mAb 12B1. 
GAPDH served as a control. The asterisk indicates the nonspecific band 
detected in PC12 cells. (b) Ca+ current recordings. Seven independent ex-
periments were performed for each cell line, and the data were combined 
each to obtain the indicated n values. Shown are the means ± SEM for the 
indicated n values. Paired Student’s t test. *, P < 0.05. (B) BARP down-
regulates endogenous Ca2+ channel activity in PC12 cells. PC12 cells were 
transfected with a vector carrying WT or mutated BARP and EGFP cDNAs. 
Cells expressing EGFP were selected for electrophysiology. I–V relationships 
of Ca2+ channels for cells expressing the different BARP proteins are shown. 
Three independent experiments were performed, and the data were com-
bined to obtain the indicated n values. Shown are the means ± SEM. Paired 
Student’s t test at 20 mV: control versus BARP WT or domains I and II mu-
tated (P < 0.01). (C) BARP inhibits Ca2+-triggered growth hormone secretion 
in PC12 cells. PC12 cells were cotransfected with cDNAs for hGH and either 
-galactosidase, synaptotagmin I, or WT or mutated BARP. hGH secretion in 
response to high K+ stimulation from cells coexpressing hGH and -galactosi-
dase was used as a control (100%). Shown are the means ± SEM; n = 4 in-
dependent experiments; unpaired Students t test: *, P < 0.05. (D) BARP does 
not affect cell surface expression of Ca2+ channels in PC12 cells. (a) Cell sur-
face expression of N-EGFP/HA-Cav1.2 and N-Myc–BARP monitored in the 
presence or absence of Cav3 by immunofluorescence microscopy. PC12 
cells were electroporated with cDNAs for N-EGFP/HA-Cav1.2 alone (A) ei-
ther together with N-Flag–Cav3 (B) or N-Myc–BARP (C) or with Flag-Cav3 
and WT BARP or BARP with mutated domains I and II (D and E). Cav1.2 and 
BARP expressed at the cell surface in nonpermeabilized cells were detected 
using Ab to the extracellular HA epitope in Cav1.2 and Myc in BARP. Cel-
lular expression of EGFP-Cav1.2 and Cav3 are shown. Merged images 
are shown on the right. (b) Quantification of channel cell surface expression 
is expressed as the relative surface expression of HA versus EGFP-Cav1.2 (red/
green). Shown are the means ± SEM. Unpaired Student’s t test: *, P < 0.01. 
db, both domains I and II mutated; Dom., domain.
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Figure 8. Silencing of BARP enhances VGCC activ-
ity and Ca2+-evoked secretion. (A) Silencing of BARP 
enhances VGCC Ca2+ currents. (a) Schematic loca-
tion of three BARP shRNA target sequences (A–C) 
in the rat BARP mRNA. (b) Silencing of endogenous 
BARP by shRNAs. WB detection of endogenous 
BARP and GAPDH in lysates from either ATCC 
PC12 control cells or cells constitutively expressing 
single BARP shRNAs. The asterisk shows a non-
specific band detected in PC12 cells. Two clones 
for each shRNA were selected, and BARP (mAb 
12B1) and GAPDH were detected. (c) Quantifica-
tion of the efficiency of BARP shRNA knockdown. 
WBs were scanned, and the density values for the 
BARP protein bands were normalized to those of 
the respective GAPDH bands. The relative amount 
of BARP present in control PC12 cells was set to 1. 
Means ± SEM are shown for n = 5; unpaired Stu-
dent’s t test control versus shRNA-expressing clones: 
*, P < 0.01. (d) Ca2+ current density recordings in 
PC12 control cells and cells stably expressing BARP 
shRNAs. The control current was set to 100. For res-
cue experiments (red bars), cells expressing BARP 
shRNAs were transfected with a BARP mouse cDNA 
with a different codon usage. Means ± SEM are 
shown for eight (silencing) and four (rescue) experi-
ments, and the data were combined to obtain the 
indicated n values; unpaired Student’s t test con-
trol versus shRNA-expressing clones: *, P < 0.05. 
(B) Silencing of BARP enhances Ca2+-evoked secretion. 
(a) Schematic location of the two BARP siRNA target 
sequences (A and B) in the rat sequence. (b) Silenc-
ing of endogenous BARP by siRNAs. WB detection 
of endogenous BARP (mAb 12B1) and -tubulin as 
a control in lysates from ATCC PC12 cells or cells 
transfected with both siRNAs. Three independent 
experiments were performed, and a representative 
example is shown. (c) Acetylcholine secretion was 
determined in control and siRNA-transfected PC12 
cells after low or high potassium stimulation. Shown 
are the means ± SEM; n = 4 independent experi-
ments; unpaired Student’s t test: *, P < 0.05.
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In brief, cerebella were removed from 19-d Wistar rat fetuses, minced in 
Ca2+/Mg2+-free Hank’s saline (Gibco), and digested with 0.01% trypsin 
(15 min at 37°C). After trituration, the suspension was plated at 5,000 
cells/mm2 on 18-mm glass coverslip (Thermo Fisher Scientific) coated 
with poly-l-lysine and poly-l-ornithine. Culture medium (37°C at 5% CO2) 
consisted of glutamate/aspartate-free DMEM/F12 supplemented with 
10 mg/ml bovine insulin, 100 mg/ml BSA, 1 mg/ml gentamycin, 200 mg/ml 
glutamine, 100 mg/ml human apotransferrin, 40 nM progesterone, 100 nM 
putrescine, 30 nM sodium selenite, 500 pg/ml triiodothyronine, 3% heat-
inactivated horse serum (Gibco), and 25% of astrocyte-conditioned me-
dium (Sumitomo Corp.), renewed by half twice a week. Cells were used 
at 3–4 wk. All animal experimentation was approved by the RIKEN or 
Institute of Molecular and Cell Biology Institutional Animal Care and Use 
Committees. Cells were maintained in culture for 3–4 wk before immunofluor-
escence microscopy experiments. Tunicamycin treatment was performed 
by incubating COS-1 cells immediately after transfection for 2 d with 
10 µg/ml tunicamycin (Sigma-Aldrich).
Immunoprecipitation and Western blot (WB) analysis
Cell homogenates were prepared in lysis buffer (50 mM Tris-HCl, pH 7.5, 
100 mM NaCl, 1 mM MgCl2, and 0.5% Triton X-100) supplemented with 
protease inhibitors and used for coimmunoprecipitation and WB analysis 
as previously described (Béguin et al., 2006). For better resolution of 
higher molecular weight proteins, some samples were run on Tris-acetate 
gels (7%) according to the manufacturer’s instructions (Invitrogen). Rat mAb 
to HA (Roche), mouse mAb to Flag (M2; Sigma-Aldrich), Cav1 (Neuro-
Mab), GAPDH, MAP2, calbindin (EMD Millipore), synaptotagmin (Stress-
gen), GST (Santa Cruz Biotechnology, Inc.), Cav3 (Alomone Labs), GFAP 
(Sigma-Aldrich), and Ab to BARP (72 and 8B2) were used. Rat cerebrum 
and cerebellum were manually dissociated and immediately homogenized 
in the same lysis buffer using 15 strokes of a glass Teflon homogenizer fol-
lowed by one freeze/thaw cycle. Insoluble material was removed by cen-
trifugation. Brain, skeletal muscle, and heart lysates were purchased from 
Zyagen Laboratories. At least three independent experiments were per-
formed, and representative examples are shown.
In vitro transcription/translation
BARP was synthesized in vitro using the quick-coupled transcription/trans-
lation system (TnT; Promega) according to the manufacturer’s protocol.
In vitro peptide competition
For dissociation experiments, AID (445AKARGDFQKLREKQQLEEDLKGAL-
DAATQAED476) and BARP domain I (422SYRDLWSLRASLELHAATASD442) pep-
tides were synthesized (Mimotopes). Cav3 was pulled down from cell 
lysates with a GST-AID (aa A445–D476) fusion protein. After extensive 
washing in lysis buffer (50 mM Tris-HCl, pH 7.5, 100 mM NaCl, 1 mM 
MgCl2, and 0.5% Triton X-100) supplemented with protease inhibitors to 
remove unbound Cav3, increasing concentrations of peptides (30, 60, 
300, and 600 nM) were added in lysis buffer. After a 4-h incubation on 
ice, 10% of the supernatant containing any dissociated Cav3 was ana-
lyzed by SDS-PAGE and WB. In the absence of competitive peptides, the 
GST-AID–Cav3 subunit complex remained stable over the 4-h incubation 
period. At least three independent experiments were performed, and rep-
resentative examples are shown.
Immunocytochemistry and immunohistochemistry
N-Flag–Cav subunits and BARP or N-Myc–BARP overexpressed in PC12 
and COS-1 cells were stained with mouse anti-Flag (M2; Sigma-Aldrich) 
and rabbit anti-BARP Ab 72 or a rabbit Ab to Myc (Sigma-Aldrich) fol-
lowed by Cy3-labeled donkey anti–rabbit IgG (Jackson ImmunoResearch 
Laboratories, Inc.) and Alexa Fluor 488 goat anti–mouse IgG (Molecular 
Probes) secondary Ab as previously described (Béguin et al., 2005b). 
PC12, primary hippocampal, or cerebellar cells were stained with rab-
bit Ab to MAP2 (EMD Millipore), calbindin (EMD Millipore), and GFAP 
(Sigma-Aldrich), BDNF (EMD Millipore), or with mouse mAb to synaptotag-
min (Stressgen). Rat brains were mechanically cut into 0.3-µm-thick sections 
and incubated in 10% TCA for 30 min before staining. Mouse pancreas 
was fixed in 4% PFA and subjected to standard ethanol/xylene process-
ing, embedded into paraffin, cut into 0.5-µm sections, and rehydrated in 
graded ethanol. Slices were then washed three times with 30 mM PBS-
glycine and incubated 1 h in a blocking buffer (10% goat serum, 2% BSA, 
and 0.4% Triton X-100), and Ab incubations were performed as described 
in this paragraph. For the 72 BARP Abs, antigen retrieval was achieved 
by incubating fixed slices for 30 min in 10 mM Tris-HCl, pH 9.0, 1 mM 
EDTA, and 0.05% Tween 20 at 80°C followed by three washes in PBS 
Ca2+ channel modulators. The identification of BARP may 
thus open new avenues for the design of novel therapeutic 
VGCC blockers.
Materials and methods
Molecular biology
The yeast two-hybrid screens were performed as follows. A yeast strain L40 
(MATa trp1 leu2 his3 LYS2::lexA-HIS3 URA3::lexA-lacZ) was transformed 
with a derivative of pBTM116 encompassing Cav3 subunit amino acid 
residues 50–484 fused to the LexA DNA-binding domain. A mouse MIN6 
cell cDNA library was then screened, and after histidine selection, positive 
clones were further confirmed to be true positives by -galactosidase activ-
ity measurement. Eight positive clones that presented fragments of BARP 
cDNA were found. A BARP alanine mutagenesis scan for aa 280–485 was 
assessed by substituting three by three the amino acids of BARP to alanine 
and processed for -galactosidase activity measurements using paper filters 
stained with 5-bromo-4-chloro-3-indolyl--d-galactopyranoside (Béguin et al., 
2001). Full-length mouse BARP was isolated by conventional screening of 
MIN6 cDNA libraries with a partial mouse cDNA. Sequence analysis of 
EST clones from mouse, rat, and human (see legend of Fig. S1 A) confirmed 
that BARP is translated from a 3-kb transcript. Rat Cav1b, Cav21 (e.g., 
2A), Cav3, and Cav1.2 were originally cloned in S. Seino’s laboratory, 
and the Cav2.1 and Cav2.2 cDNAs were a gift from T.W. Soong (National 
University of Singapore, Singapore) and T.P. Snutch (University of British 
Columbia, Vancouver, British Columbia, Canada). Mouse Cav4a was ob-
tained from the I.M.A.G.E. Consortium (4501980). Epitope-tagged con-
structs (Flag, HA, Myc, GST, and EGFP) as well as deletion and point 
mutants were generated by PCR-based methods and subcloned into the 
pME18S vector containing an SR promoter. The internally HA-tagged 
Cav1.2 has been described elsewhere (Altier et al., 2002; Béguin et al., 
2006). In brief, the HA sequence was introduced in the S5-H5 loop in posi-
tion 697 of rabbit Cav1.2. The amino acid sequence is defined as MQTRH-
HA-MQTR (MQTR are amino acids of Cav1.2, which were duplicated, 
underlined is an additional amino acid, and the HA sequence is without the 
first methionine). Northern blot analysis was performed under standard 
stringency hybridization and washing conditions using mouse and human 
BARP cDNA probes.
Ab production
Polyclonal anti-BARP Ab 72 was custom made (BioGenes) by injecting rab-
bits with a BARP peptide (131NEAALFEQSRK141) conjugated to hemocyanin 
and affinity purified. A GST-BARP fusion protein (aa G125-A698) was in-
jected into mice to generate mAb 12B1 and 8B2. Epitope mapping using 
truncated forms of BARP located the epitopes recognized by 8B2 and 
12B1 to a region between aa 380 and 698.
Cell culture and transfection
COS-1, standard (CRL-1721), and Tet-On PC12 cells as well as BHK and 
tsA201 cells were grown and transiently transfected with WT or mutated 
cDNAs using Lipofectamine (LTX; Invitrogen) and jetPRIME (Polyplus Trans-
fection) for biochemical and immunofluorescence experiments, respec-
tively (Béguin et al., 2001, 2005b, 2006, 2007; Mahalakshmi et al., 
2007a,b). A plasmid carrying a hygromycin resistance gene and the BARP 
cDNA downstream of a cytomegalovirus promoter was transfected into 
PC12 cells using Lipofectamine LTX. PC12 clones stably overexpressing 
BARP were selected and maintained in 0.2 µg/µl hygromycin. BHK cells 
expressing functional Ca2+ channels reconstituted by expression of rabbit 
cDNAs for the different subunits have been characterized (Mori et al., 
1991; Fujita et al., 1993). Silencing of BARP in PC12 cells was achieved 
using the pSUPER RNAi System (Oligoengine) system and shRNAs A 
(5-TTCTCAAGTCCATATACGG-3), B (5-TAGTGTTGATTGTCCTCCT-3), and C 
(5-CTTTGTAGCAACTGTACCT-3) with selection and maintenance of sta-
ble clones in 400 µg/ml G418. Alternatively, PC12 cells were transiently 
transfected using DharmaFECT (Thermo Fisher Scientific) with siRNAs A 
(5-GGAUUUCCAUCACCUCAAG-3) and B (5-CAUGCUGACUUCAUU-
CAAU-3) designed by Thermo Fisher Scientific and used for analysis 48 h 
after transfection. For cell surface expression analysis, PC12 cells were 
electroporated (1,410 V at 30 ms) using the Neon Transfection System 
(Invitrogen). Primary hippocampal neurons were purchased from Cam-
brex and cultured according to the manufacturer’s instructions. Cerebel-
lar primary cultures were prepared as previously described (Launey et al., 
2004) with substitution of B27 by the N21 supplement (Chen et al., 2008). 
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expressing EGFP and mCherry were selected for measurements. For each 
cell, current density (IBa) was calculated by dividing the total current by the 
membrane capacitance. The holding potential was –60 mV, and test pulses 
of 400 ms at potentials between 40 and 60 mV in steps of 10 mV were 
applied every 4 s. The membrane potential was measured by the perforated 
patch clamp method in the current clamp mode as previously described 
(Gonoi et al., 1994).
Growth hormone secretion and membrane potential
Secretion of transfected human growth hormone (hGH) or acetylcholine 
by PC12 cells were assayed as described previously (Béguin et al., 2001; 
Kiyonaka et al., 2007). In brief, PC12 cells were cotransfected with 
pXGH5 vector (Nichols Institute) containing an SR promoter driving WT 
or mutated BARP, using Lipofectamine (Invitrogen) according to the manu-
facturer’s instructions. After 3 d, PC12 cells were washed with a physiolog-
ical salt solution (PSS; 140 mM NaCl, 4.7 mM KCl, 2.5 mM CaCl2, 
1.2 mM MgCl2, 1.2 mM KH2PO4, 20 mM Hepes, pH 7.4, and 11 mM 
glucose) and incubated for 10 min with a high K+ solution (PSS containing 
60 mM KCl and 85 mM NaCl) or a low K+ solution (PSS containing 4.7 mM 
KCl and 140 mM NaCl). Growth hormone was measured with a colorimet-
ric immunoassay kit (Roche). Acetylcholine secretion in PC12 cells (Kiyonaka 
et al., 2007) was assayed with the similar basic procedure with the ex-
ception that pXGH5 was replaced by pEFmChAT cDNA, and acetylcho-
line release was measured using HPLC with electrochemical detection 
(HTEC-500; EiCOM).
Molecular modeling
In silico modeling, molecular dynamics, and energy refinements were per-
formed using the Sybyl 7.2 software package (Tripos, Inc.). The Cav sub-
unit crystal structure (Protein Data Bank accession no. 1VYT) was used as 
a template to dock the BARP domain I. This domain was modeled as an  
helix in a reverse orientation. Amino acid W427 of BARP was positioned 
similarly to residue W440 of AID followed by molecular dynamics simula-
tions (1,000 fs with 1-fs steps at 300 K) between residues of the Cav sub-
unit and domain I within 6 Å. The lowest energy conformation was then 
obtained by energy minimization using Powell’s method (Fletcher and Pow-
ell, 1963). The -helical model of domain I shown in Fig. S3 D was gener-
ated using Phyre2 (Kelley and Sternberg, 2009).
Data and statistical analysis
Statistical significances were tested using unpaired and paired Student’s 
t tests, and results were expressed as means ± SEM for the indicated n val-
ues. For coprecipitation, pull-down, WB, and immunofluorescence micros-
copy experiments, at least three independent experiments were performed, 
and a representative example is shown.
Online supplemental material
Fig. S1 shows alignment of BARP protein sequences of different species, 
evidence for the specificity of antibodies to BARP, and the assignment of 
the initiation methionine and glycosylation of BARP. Fig. S2 shows expres-
sion of BARP during mouse development, evidence for the specificity of 
the antibodies for immunohistochemistry localization of BARP in brain and 
pancreas, localization of overexpressed BARP and overexpressed synap-
totagmin I, and membrane localization of Cav subunit isoforms by BARP. 
Fig. S3 shows the identification of domains and amino acids in BARP that 
mediate the interaction with Cav and molecular dynamics modeling of 
the interaction of BARP domain I with the ABP of Cav. Fig. S4 charac-
terizes the effect of BARP on the association of the Cav with the Cav1 
subunit and the association of BARP with different Cav subunit isoforms in 
brain. Fig. S5 analyzes the effect of BARP on VGCC activity and surface 
expression and presents a working model for BARP as a Cav-anchoring 
protein. Online supplemental material is available at http://www.jcb 
.org/cgi/content/full/jcb.201304101/DC1.
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before blocking. Antigen retrieval in pancreas sections was performed in 
citrate buffer (10 mM sodium citrate, pH 6, and 0.05% Tween 20) in an 
autoclave (Retriever 2100; Prestige Medical). Mouse mAb to glucagon 
(Abcam) or guinea pig Ab to insulin (Abcam) was used to stain  and 
 cells, respectively, in pancreatic islets. Labeled specimens were mounted 
in FluorSave (Vector Laboratories) or ProLong Gold (Invitrogen) and visual-
ized using a confocal microscope (LSM 510 Meta [Carl Zeiss] or FluoView 
FV1000 [Olympus]). Antigen preabsorption experiments were performed 
by incubating GST-BARP (G125-A698) fusion protein (1 µg) linked to Sep-
harose beads with anti-Myc and anti-BARP Ab (72, 12B1, or 8B2) in lysis 
buffer for 2 h at 4°C. After a short centrifugation, the supernatant was col-
lected and mixed with blocking buffer (1:1) before being applied to PFA-fixed 
cells expressing N-Myc–BARP or cerebellum slices fixed in 10% TCA.
Cell surface expression assays
To detect cell surface expression of N- or C-terminally tagged BARP or a 
Cav1.2 carrying a tag in an extracellular loop (Béguin et al., 2001; Altier 
et al., 2002), we took advantage of the fact that Abs to the tags when 
added to nonpermeabilized intact cells only bind and label the cells if the 
tag is exposed on the cell surface. Thus, intact transfected COS-1, tsA201, 
or BHK cells were incubated with 2 µg/ml rat anti-HA (Roche) and/or 
1 µg/ml rabbit anti-Myc Ab (Sigma-Aldrich) for 1 h and then washed twice 
in ice-cold PBS before fixation. In some experiments, the cells were sub-
sequently permeabilized and incubated with a different Ab to detect an intra-
cellular protein such as the Cav subunits and EGFP-Cav1.2 in the same 
cells. Visualization by immunofluorescence microscopy was as described 
in the previous section.
Quantification of surface channel expression was performed as fol-
lows: a random 540 × 540–µm area was scanned for each coverslip at 
488 nm (EGFP-Cav1.2 cell expression), 546 nm (Cav1.2 surface expres-
sion), and 633 nm (N-Myc–BARP surface expression) using a microscope 
(Eclipse Ti; Nikon; 20×, 1.0 NA oil objective) with a motorized stage with 
NIS element AR software version 4.0 (Nikon). Cells expressing Cav1.2 alone 
or with Cav3 were first selected blindly based on EGFP fluorescence only 
(reflecting Cav1.2 total expression) and segmented, without looking at the 
surface expression. The mask thus defined was then applied to all fluoro-
phores, and mean pixel intensity for each cell was calculated, yielding 
Cav1.2 total expression (488 nm) and relative surface localization (546/488 
nm). Cell surface expression of Cav1.2 with Cav3 together with BARP WT 
or domain I and II mutated was performed by first blindly selecting cells ex-
pressing BARP (633 nm), without looking at the total or surface expression 
of EGFP-Cav1.2. Again, the thus defined regions of interest were used as a 
mask to measure mean pixel intensity for each cell and each channel. To as-
certain that quantification is not affected by Cav1.2 cellular expression, a 
cutoff corresponding to half of the mean pixel intensity of EGFP-Cav1.2 in the 
absence of BARP was applied.
Colocalization analysis
Fluorescence colocalization was quantified using the ImageJ/Fiji (National 
Institutes of Health; Schneider et al., 2012) with the plugin Coloc 2 (ver-
sion December 2011), after confocal image acquisition with 62-nm/pixel 
spatial oversampling (FluoView FV1000 confocal with 100×, 1.4 NA oil 
objective, software version 4.0). For each cell, five independent optical 
sections were acquired at low noise (Kalman filter 5), sequentially for each 
channel, with negligible bleed through between channels. For accurate 
sampling of the different cell compartments, the five sections were pro-
jected into single images (one per channel) before background subtraction 
and colocalization analysis. Region of interest was defined automatically 
by applying a logical OR operation the two segmented channels, to select 
pixels that are above background in each channel. The colocalization index 
is reported as the thresholded Pearson’s correlation coefficient, as it is more 
robust than other metrics (Adler and Parmryd, 2010). For each condition, at 
least 13–30 cells from three independent replicates were analyzed.
Electrophysiology
Whole-cell patch clamp recordings were made on BHK, PC12, and tsA201 
cells using bath solution containing 40 mM Ba2+ at 37°C as previously de-
scribed (Béguin et al., 2001, 2006). In brief, to obtain expression of EGFP 
and BARP, the WT or mutated BARP cDNAs were transfected into the P/Q or 
N type–expressing BHK cell lines or PC12 cells using the pCMS-EGFP vector 
(Takara Bio Inc.). Cells expressing the EGFP were selected for measurements. 
For expression in the tsA201 cells, WT and mutated BARP cDNA were 
cloned into a pCMS-EGFP vector in which EGFP had been replaced by 
mCherry and cotransfected with a pCMS-EGFP vector carrying the cDNAs 
for Cav1.2 and Cav3 separated by an internal ribosomal entry site. Cells 
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